{
    "success": true,
    "data": {
        "id": 1661345,
        "msgid": "ipmg-pushes-for-access-and-availability-of-innovative-medicines-for-patients-1775606628",
        "date": "2026-04-07 16:22:00",
        "title": "IPMG Pushes for Access and Availability of Innovative Medicines for Patients",
        "author": "indrastuti",
        "source": "MEDIA_INDONESIA",
        "tags": "",
        "topic": "Regulation",
        "summary": "The International Pharmaceutical Manufacturers Group (IPMG), representing 25 global research-based pharmaceutical companies, has announced its new board for 2026\u20132028, with Evie Yulin of Merck Indonesia re-elected as Chair and George Stylianou of MSD Indonesia as Vice Chair. The leadership aims to bridge the gap in access to innovative medicines in Indonesia, where only about 9% are available and 2% are covered by public funding, through stronger collaboration with the government and policy advocacy. This initiative supports Indonesia's Golden Vision 2045 by promoting transparent regulations, ethical standards, and a robust healthcare system to enhance national competitiveness and patient outcomes.",
        "content": "<p>The International Pharmaceutical Manufacturers Group (IPMG), an\nassociation of multinational research-based pharmaceutical companies,\nhas officially announced the composition of its Board of Directors for\nthe 2026\u20132028 period. In this announcement, Evie Yulin (President\nDirector of Merck Indonesia) has been re-elected as Chair of IPMG,\nsupported by George Stylianou (President Director of MSD Indonesia) as\nVice Chair.<\/p>\n<p>This leadership duo is expected to strengthen the association\u2019s\nvision, which represents 25 global pharmaceutical companies in promoting\nbroader healthcare access for patients in Indonesia.<\/p>\n<p>The newly elected IPMG Chair, Evie Yulin, stated that the main focus\nof her tenure is to bridge the gap in access to innovative medicines.\nShe highlighted data indicating that the availability of innovative\nmedicines in the country remains very limited.<\/p>\n<p>\u201cCurrently, only around 9% of innovative medicines are available in\nIndonesia, and only about 2% can be accessed through public funding.\nBridging this gap remains IPMG\u2019s top priority,\u201d said Evie in her\nofficial statement on Tuesday (7\/4\/2026).<\/p>\n<p>Evie emphasised the importance of strong collaboration with the\ngovernment to ensure more patients receive the benefits of the latest\ntreatments, while supporting the Golden Indonesia 2045 vision. IPMG is\ncommitted to promoting a transparent and predictable policy\nenvironment.<\/p>\n<p>Several strategic points that the new board will oversee include\nstrengthening the implementation of Health Technology Assessment (HTA),\ndeveloping sustainable pricing and procurement mechanisms, and aligning\nregistration pathways with patient funding.<\/p>\n<p>In line with this, IPMG Executive Director Ani Rahardjo expressed the\nassociation\u2019s readiness to continue playing a constructive role in\nnational policy dialogues.<\/p>\n<p>\u201cWe remain open to collaboration to build a more resilient healthcare\nsystem and enhance Indonesia\u2019s competitiveness,\u201d added Ani.<\/p>\n<p>In addition to access aspects, IPMG reaffirmed its commitment to\nmaintaining industry ethical standards. The association adopts the Code\nof Practice from the International Federation of Pharmaceutical\nManufacturers and Associations (IFPMA) as a guide for interactions with\nhealthcare professionals and medical institutions.<\/p>\n<p>This step is taken to ensure the integrity of the healthcare\necosystem, prevent corrupt practices, and protect the broader public\ninterest.<\/p>\n<p>The 2026\u20132028 Board of Directors is strengthened by experts in\nvarious fields, from regulation and health investment to patient safety.\nThrough this new composition, IPMG aims to affirm the message that\nhealth is not merely a cost, but a strategic investment to realise a\nproductive and globally competitive nation.<\/p>",
        "url": "https:\/\/jawawa.id\/newsitem\/ipmg-pushes-for-access-and-availability-of-innovative-medicines-for-patients-1775606628",
        "image": ""
    },
    "sponsor": "Okusi Associates",
    "sponsor_url": "https:\/\/okusiassociates.com"
}